Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2022
Kidney disease drug dapagliflozin added to Pharmaceutical Benefits Scheme
31 August 2022 - Lachlan Ross describes his more than a decade-long battle with kidney failure as "very long, and very ...
Posted by Michael Wonder on 31 Aug 2022
Schedule of Pharmaceutical Benefits - 1 September 2022
1 September 2022 - The September 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Aug 2022
First new kidney treatment in 20 years delays dialysis and transplant
31 August 2022 - Kidney disease is Australia’s silent killer, with nine in 10 patients unaware they have it until too ...
Posted by Michael Wonder on 28 Aug 2022
Ovarian cancer drug that costs up to $130k will soon be affordable for hundreds of patients
28 August 2022 - A drug that works to prolong survival for some patients with advanced ovarian cancer is being ...
Posted by Michael Wonder on 26 Aug 2022
Agenda for the September 2022 PBAC intracycle meeting
26 August 2022 - The agenda for the September 2022 PBAC intracycle meeting is now available.
...
Posted by Michael Wonder on 26 Aug 2022
PBAC Public Summary Documents – May 2022 meeting
26 August 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2022 PBAC ...
Posted by Michael Wonder on 22 Aug 2022
National Medicines Policy review – registrations for targeted stakeholder consultation sessions and open public forum
22 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on the revised ...
Posted by Michael Wonder on 19 Aug 2022
Recommendations made by the PBAC - July 2022
19 August 2022 - The recommendations from the July 2022 PBAC meeting are now available. ...
Posted by Michael Wonder on 19 Aug 2022
1 September 2022 updates as part of the digital transformation of authority required (written) PBS listings
19 August 2022 - From 1 September 2022, the PBS listings for certain cancer medicines will be updated as part of ...
Posted by Michael Wonder on 18 Aug 2022
Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes
18 August 2022 - Medicines Australia welcomes the restart of the National Medicines Policy Review, which was put on hold ...
Posted by Michael Wonder on 17 Aug 2022
Fears for patient safety with hundreds of medicines in short supply
17 August 2022 - Doctors and pharmacists are warning there could be serious consequences for patients if the shortage of hundreds ...
Posted by Michael Wonder on 17 Aug 2022
Restart of the National Medicines Policy review – further consultation on a revised draft
17 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised ...
Posted by Michael Wonder on 07 Aug 2022
Australians forced to pay for methadone and other drugs to get off addictive PBS medication
7 August 2022 - Aussie taxpayers are subsidising addictive pain medication but not the treatments that help get patients off the ...
Posted by Michael Wonder on 04 Aug 2022
Panicked patients as popular medications get wiped from pharmacy shelves
4 August 2022 - Widely used medications — including one used to treat ADHD — are missing from Australian shelves amid ...
Posted by Michael Wonder on 01 Aug 2022
Changes to cost recovery arrangements from 1 August 2022
1 August 2022 - PBS cost recovery fees and charges have now been updated with the fees that will apply ...